✦ LIBER ✦

An update on molecularly targeted therapies in second- and third-line treatment in non-small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents

✍ Scribed by Majem, M.; PallarÃ¨s, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-Line Treatment Options in Non–Sma

✍ Filippo de Marinis; Stefano De Santis; Luigi De Petris 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

9081 POSTER Network Meta-analysis of Sec

✍ Bianic, F.; Despiegel, N.; Cure, S.; Campbell, J.; Wang, Z.; Cappelleri, J.C.; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PD-068 An exploratory analysis of a phas

✍ Bunn, P.; Rosell, R.; Fossella, F.; Perry, M.; Stahel, R.; Barata, F.; Nguyen, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB